(Q42280014)

English

Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients.

scientific article published on August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Anna Casati

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Azam Varghaei-Nahvi

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Steven Alexander Feldman

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Steven Aaron Rosenberg

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Mark Edward Dudley

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2013

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

62

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1563-1573

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

https://scigraph.springernature.com/pub.10.1007/s00262-013-1459-x

0 references

Adoptive immunotherapy for cancer: harnessing the T cell response

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Adoptive T cell therapy of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Adoptive immunotherapy for cancer: building on success

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Optimization of culture conditions for activation and large-scale expansion of human T lymphocytes for bispecific antibody-directed cellular immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Selected murine residues endow human TCR with enhanced tumor recognition

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

T-Cell Function and Migration — Two Sides of the Same Coin

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Pathways of memory CD8+ T-cell development

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1459-X

21 January 2018

Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/23903715

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospects and limitations of T cell receptor gene therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23903715

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Raising the bar: the curative potential of human cancer immunotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23903715

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00262-013-1459-X

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Dimensions Publication ID

0 references

release_qvvzykwb4zhudicbd6z3lldyym

1 reference

https://api.fatcat.wiki/v0/release/qvvzykwb4zhudicbd6z3lldyym

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903715%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42280014&oldid=1837675466"